21 related articles for article (PubMed ID: 16736599)
1. CanScript, an 18-Base pair DNA sequence, boosts tumor cell-specific promoter activity: implications for targeted gene therapy.
Huang YH; Cozzitorto JA; Richards NG; Eltoukhy AA; Yeo CJ; Langer R; Anderson DG; Brody JR; Sawicki JA
Cancer Biol Ther; 2010 Nov; 10(9):878-84. PubMed ID: 20798601
[TBL] [Abstract][Full Text] [Related]
2. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters.
Iyer M; Wu L; Carey M; Wang Y; Smallwood A; Gambhir SS
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14595-600. PubMed ID: 11734653
[TBL] [Abstract][Full Text] [Related]
3. LucFlow: A method to measure Luciferase reporter expression in single cells.
Nooti S; Naylor M; Long T; Groll B; Manu
PLoS One; 2023; 18(10):e0292317. PubMed ID: 37792708
[TBL] [Abstract][Full Text] [Related]
4. Construction of modular and versatile plasmid vectors for the high-level expression of single or multiple genes in insects and insect cell lines.
Huynh CQ; Zieler H
J Mol Biol; 1999 Apr; 288(1):13-20. PubMed ID: 10329122
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of luciferase activity of viral and hybrid promoters in bovine preimplantation embryos.
Nakamura A; Okumura J; Muramatsu T
Mol Reprod Dev; 1998 Apr; 49(4):368-73. PubMed ID: 9508087
[TBL] [Abstract][Full Text] [Related]
7. Cre-loxP system as a versatile tool for conferring increased levels of tissue-specific gene expression from a weak promoter.
Nakamura S; Watanabe S; Ohtsuka M; Maehara T; Ishihara M; Yokomine T; Sato M
Mol Reprod Dev; 2008 Jun; 75(6):1085-93. PubMed ID: 18163444
[TBL] [Abstract][Full Text] [Related]
8. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
9. Artificial promoters for metabolic optimization.
Jensen PR; Hammer K
Biotechnol Bioeng; 1998 Apr 20-May 5; 58(2-3):191-5. PubMed ID: 10191389
[TBL] [Abstract][Full Text] [Related]
10. Identifying and engineering promoters for high level and sustainable therapeutic recombinant protein production in cultured mammalian cells.
Ho SC; Yang Y
Biotechnol Lett; 2014 Aug; 36(8):1569-79. PubMed ID: 24737078
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the relative luciferase activity in secondary CEF by different heterogenous strong promoters, MDV gB promoter and the composed promoters].
Qiu YF; Ge FF; Xu XQ; Chen PY
Wei Sheng Wu Xue Bao; 2006 Apr; 46(2):314-7. PubMed ID: 16736599
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
